Key Developments For Animal Health International, Inc.
Animal Health International, Inc. (AHII.O) (Nasdaq)
Animal Health International, Inc. Issues Q2 2010 Guidance; Earnings Guidance Below Analysts' Estimates; Reaffirms FY 2010 Guidance
Animal Health International, Inc. announced that for fiscal 2010 it expects revenue to be in the range of $650 to $685 million, EBITDA to be in the range of $22 to $27 million and net income is expected to be $2.3 to $5.3 million or $0.09 to $0.22 per share. Revenue for the second quarter 2010 is expected to be $170 to $175 million, EBITDA is estimated to be $4.5 to $5.5 million and net earnings are expected to be between a loss of $0.2 million and a profit of $0.4 million, or ($0.01) to $0.02 per share. According to Reuters Estimates, analysts are expecting the Company to report revenue of $172 million, EBITDA of $5.8 million and EPS of $0.10 for second quarter 2010; revenue of $662 million and EBITDA of $22 million for fiscal 2010.
Animal Health International, Inc. Issues Q1, FY 2010 Outlook; Q1 2009 Outlook Below Analysts' Estimates; FY 2010 Revenue Outlook In Line With Analysts' Estimates; EPS Outlook Below Estimates
Animal Health International, Inc. announced that for the first quarter of 2010, revenue is expected to be $150 to $155 million. EBITDA is estimated to be $2.5 to $3.5 and net loss is expected to be $2.0 to $1.0 million or $0.08 to $0.04 per share. For fiscal 2010, revenue is expected to be $650 to $685 million. EBITDA is estimated to be $22 to $27 million and net income is expected to be $2.3 to $5.3 million or $0.09 to $0.22 per share. According to Reuters Estimates, analysts were expecting the Company to report revenue of $167 million, EBITDA of $6.30 million, net profit of $2.40 million and EPS of $0.07 for the first quarter of 2010; revenue of $666 million, EBITDA of $24 million, net profit of $3.92 million and EPS of $0.33 for fiscal 2010.
Animal Health International, Inc. Issues FY 2009 Guidance Below Analysts' Estimates
Animal Health International, Inc. announced that for fiscal 2009, it expects net sales to be in the range of $645-$660 million. EBITDA, excluding any one-time charges, is estimated to be in the range of $22.0-$25.0 million, and net income to be in the range of $2.1-$3.7 million. According to Reuters Estimates, analysts are expecting the Company to report net profit of $6.7 million; EBITDA of $28.8 million on revenues of $671 million for the same period.
Animal Health International, Inc. Reaffirms FY 2009 Outlook
Animal Health International, Inc. confirmed its guidance for fiscal 2009. Net sales for fiscal 2009 are expected to be in the range of $650 to $680 million. EBITDA is estimated to be in the range of $29.0 to $33.0 million, and its net income to be in the range of $7.3 to $9.3 million. This excludes any projections of future acquisitions. According to Reuters Estimates, analysts were expecting the Company to report revenue of $670 million and EBITDA of $31 million for the same period.
Animal Health International, Inc. Enters Livestock Products Pact With Pfizer-DJ
Dow Jones reported that Animal Health International, Inc. said that its Walco International Inc. unit and Pfizer Inc. entered into a livestock products distribution agreement effective January 1, 2009. Under the agreement, Animal Health International, Inc. is entitled to distribute certain Pfizer products to customers in the cattle and swine fields, according to a filing with the Securities and Exchange Commission. In return, Animal Health International, Inc. is entitled to certain service fees.
